Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature

The effects of atrial natriuretic peptide (ANP) on transmural myocardial blood flow distribution and the reactive hyperemic response in the presence and absence of flow-limiting coronary stenosis were examined in chronically instrumented conscious dogs. Ten-second coronary occlusion without subseque...

Full description

Saved in:
Bibliographic Details
Published in:Circulation research 1989-03, Vol.64 (3), p.600-606
Main Authors: Chu, Alan, Stakely, Adrienne, Lin, Chang-Chyi, Cobb, Frederick R
Format: Article
Language:English
Subjects:
Animals
Atrial Natriuretic Factor - pharmacology
Atrial Natriuretic Factor - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Coronary Circulation - drug effects
Coronary Disease - complications
Coronary Disease - drug therapy
Coronary Disease - physiopathology
Coronary heart disease
Dogs
Drug Evaluation, Preclinical
Heart
Hyperemia - drug therapy
Hyperemia - etiology
Hyperemia - physiopathology
Medical sciences
Microspheres
Time Factors
Vasodilation - drug effects
Wakefulness - drug effects
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4439-bcb0c1d518b9023e3a65e4721c9a03e14239ac1798a4b830f74dbd4774311b533
cites
container_end_page 606
container_issue 3
container_start_page 600
container_title Circulation research
container_volume 64
creator Chu, Alan
Stakely, Adrienne
Lin, Chang-Chyi
Cobb, Frederick R
description The effects of atrial natriuretic peptide (ANP) on transmural myocardial blood flow distribution and the reactive hyperemic response in the presence and absence of flow-limiting coronary stenosis were examined in chronically instrumented conscious dogs. Ten-second coronary occlusion without subsequent flow restriction resulted in marked reactive hyperemic responses (Doppler flow probes), mean flow debt repayment was 481±55percent;. When the 10-second coronary occlusions were followed by a 20-second partial restriction that allowed normal preocclusion coronary inflow, the subsequent reactive hyperemia was significantly augmented, mean flow debt repayment was 938±91percent; (p
doi_str_mv 10.1161/01.RES.64.3.600
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78870760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78870760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4439-bcb0c1d518b9023e3a65e4721c9a03e14239ac1798a4b830f74dbd4774311b533</originalsourceid><addsrcrecordid>eNo9kkFv1DAQhSMEKkvhzAnJB8QtW0_sxDG37XZLK62gagtXy3EmXdMkXmynq_5JfhNe7dKDNZbeN88zes6yj0DnABWcUZjfru7mFZ-zeUXpq2wGZcFzXgp4nc0opTIXjNG32bsQflMKnBXyJDspygJqKGfZ31XXoYmBuI4sore6J991qpPHaA25wW20LRI3knuvxzBMPhHnvXMtuezdjuixJbeoTbRPSK6et-hxsJrYkcQNkhuPAUeDe_c9nq_tYKMdH8jSeTdq_0zuIo4u2PC_ZbHTj0gu3MNXsnpKT--7O-fJhe11tGmOZLXnrsfo9WGcXzqYKalp5vfZm073AT8c62n283J1v7zK1z--XS8X69xwzmTemIYaaEuoG0kLhkxXJXJRgJGaMgReMKkNCFlr3tSMdoK3TcuF4AygKRk7zb4cfLfe_ZkwRDXYYLDv9YhuCkrUtaCiogk8O4DGuxA8dmrr7ZAWV0DVPkFFQaUEVcUVUynB1PHpaD01A7Yv_DGypH8-6mlt3XcpFmPDCyZAVJWQCeMHbOf6iD489tMOvdqg7uNGpY9BGYUiB1nLdKM0Twck-wc4W7V3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78870760</pqid></control><display><type>article</type><title>Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature</title><source>Freely Accessible Journals</source><creator>Chu, Alan ; Stakely, Adrienne ; Lin, Chang-Chyi ; Cobb, Frederick R</creator><creatorcontrib>Chu, Alan ; Stakely, Adrienne ; Lin, Chang-Chyi ; Cobb, Frederick R</creatorcontrib><description>The effects of atrial natriuretic peptide (ANP) on transmural myocardial blood flow distribution and the reactive hyperemic response in the presence and absence of flow-limiting coronary stenosis were examined in chronically instrumented conscious dogs. Ten-second coronary occlusion without subsequent flow restriction resulted in marked reactive hyperemic responses (Doppler flow probes), mean flow debt repayment was 481±55percent;. When the 10-second coronary occlusions were followed by a 20-second partial restriction that allowed normal preocclusion coronary inflow, the subsequent reactive hyperemia was significantly augmented, mean flow debt repayment was 938±91percent; (p&lt;0.05). Pretreatment with ANP (3μg/kg) did not alter the flow debt repayment after a 10-second occlusion without restriction (474±30percent;, NS) but attenuated the augmentation of reactive hyperemia resulting from the 20-second inflow restriction, flow debt repayment (613±±66percent;, NS). Regional myocardial blood flow to the ischemic region was measured during restricted inflow after a 10-second coronary occlusion before and after ANP pretreatment. Before ANP, subendocardial flow decreased (0.54±0.04 ml/min/g) and subepicardial flow significantly increased (1.03±0.12 ml/min/g) when compared with the nonischemk zone (subendocardial, 1.03±0.09 ml/min/g; subepicardial, 0.87±0.09 ml/ min/g, p&lt;0.05), indicating maldistribution of the restricted inflow. The resultant subendocardial-to-subepicardial ratio in the ischemic region was significantly decreased when compared with the nonischemic region (0.56±0.03 vs. 1.18±0.04, p&lt;0.05). After ANP pretreatment, subendocardial flow to the ischemic region significantly increased (0.71±0.07 ml/min/g, p&lt;0.05) and the subendocardial-to-subepicardial ratio in the ischemic zone was significantly unproved (0.91±0.10, p&lt;0.05). Myocardial flow measured daring coronary occlusion was not altered after ANP pretreatment, indicating no change in native collateral flow to the ischemic region. Myocardial oxygen consumption, aortic and left ventricular end-diastolic pressures, dP/dt, and heart rates were also not affected by pretreatment with ANP. These data indicate that ANP favorably redistributed blood flow to the subendocardium and reduced subendocardial ischemia after a transient occlusion in the presence of a flow limiting coronary stenosis. The reversal of subendocardial hypoperfusion by ANP hi the absence of alterations of intrinsic vascular reactivity or native collateral flow supports a dilation effect of ANP on the intramural arteries.</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.RES.64.3.600</identifier><identifier>PMID: 2521815</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Animals ; Atrial Natriuretic Factor - pharmacology ; Atrial Natriuretic Factor - therapeutic use ; Biological and medical sciences ; Cardiology. Vascular system ; Coronary Circulation - drug effects ; Coronary Disease - complications ; Coronary Disease - drug therapy ; Coronary Disease - physiopathology ; Coronary heart disease ; Dogs ; Drug Evaluation, Preclinical ; Heart ; Hyperemia - drug therapy ; Hyperemia - etiology ; Hyperemia - physiopathology ; Medical sciences ; Microspheres ; Time Factors ; Vasodilation - drug effects ; Wakefulness - drug effects</subject><ispartof>Circulation research, 1989-03, Vol.64 (3), p.600-606</ispartof><rights>1989 American Heart Association, Inc.</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4439-bcb0c1d518b9023e3a65e4721c9a03e14239ac1798a4b830f74dbd4774311b533</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7176679$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2521815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chu, Alan</creatorcontrib><creatorcontrib>Stakely, Adrienne</creatorcontrib><creatorcontrib>Lin, Chang-Chyi</creatorcontrib><creatorcontrib>Cobb, Frederick R</creatorcontrib><title>Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>The effects of atrial natriuretic peptide (ANP) on transmural myocardial blood flow distribution and the reactive hyperemic response in the presence and absence of flow-limiting coronary stenosis were examined in chronically instrumented conscious dogs. Ten-second coronary occlusion without subsequent flow restriction resulted in marked reactive hyperemic responses (Doppler flow probes), mean flow debt repayment was 481±55percent;. When the 10-second coronary occlusions were followed by a 20-second partial restriction that allowed normal preocclusion coronary inflow, the subsequent reactive hyperemia was significantly augmented, mean flow debt repayment was 938±91percent; (p&lt;0.05). Pretreatment with ANP (3μg/kg) did not alter the flow debt repayment after a 10-second occlusion without restriction (474±30percent;, NS) but attenuated the augmentation of reactive hyperemia resulting from the 20-second inflow restriction, flow debt repayment (613±±66percent;, NS). Regional myocardial blood flow to the ischemic region was measured during restricted inflow after a 10-second coronary occlusion before and after ANP pretreatment. Before ANP, subendocardial flow decreased (0.54±0.04 ml/min/g) and subepicardial flow significantly increased (1.03±0.12 ml/min/g) when compared with the nonischemk zone (subendocardial, 1.03±0.09 ml/min/g; subepicardial, 0.87±0.09 ml/ min/g, p&lt;0.05), indicating maldistribution of the restricted inflow. The resultant subendocardial-to-subepicardial ratio in the ischemic region was significantly decreased when compared with the nonischemic region (0.56±0.03 vs. 1.18±0.04, p&lt;0.05). After ANP pretreatment, subendocardial flow to the ischemic region significantly increased (0.71±0.07 ml/min/g, p&lt;0.05) and the subendocardial-to-subepicardial ratio in the ischemic zone was significantly unproved (0.91±0.10, p&lt;0.05). Myocardial flow measured daring coronary occlusion was not altered after ANP pretreatment, indicating no change in native collateral flow to the ischemic region. Myocardial oxygen consumption, aortic and left ventricular end-diastolic pressures, dP/dt, and heart rates were also not affected by pretreatment with ANP. These data indicate that ANP favorably redistributed blood flow to the subendocardium and reduced subendocardial ischemia after a transient occlusion in the presence of a flow limiting coronary stenosis. The reversal of subendocardial hypoperfusion by ANP hi the absence of alterations of intrinsic vascular reactivity or native collateral flow supports a dilation effect of ANP on the intramural arteries.</description><subject>Animals</subject><subject>Atrial Natriuretic Factor - pharmacology</subject><subject>Atrial Natriuretic Factor - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Disease - complications</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - physiopathology</subject><subject>Coronary heart disease</subject><subject>Dogs</subject><subject>Drug Evaluation, Preclinical</subject><subject>Heart</subject><subject>Hyperemia - drug therapy</subject><subject>Hyperemia - etiology</subject><subject>Hyperemia - physiopathology</subject><subject>Medical sciences</subject><subject>Microspheres</subject><subject>Time Factors</subject><subject>Vasodilation - drug effects</subject><subject>Wakefulness - drug effects</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNo9kkFv1DAQhSMEKkvhzAnJB8QtW0_sxDG37XZLK62gagtXy3EmXdMkXmynq_5JfhNe7dKDNZbeN88zes6yj0DnABWcUZjfru7mFZ-zeUXpq2wGZcFzXgp4nc0opTIXjNG32bsQflMKnBXyJDspygJqKGfZ31XXoYmBuI4sore6J991qpPHaA25wW20LRI3knuvxzBMPhHnvXMtuezdjuixJbeoTbRPSK6et-hxsJrYkcQNkhuPAUeDe_c9nq_tYKMdH8jSeTdq_0zuIo4u2PC_ZbHTj0gu3MNXsnpKT--7O-fJhe11tGmOZLXnrsfo9WGcXzqYKalp5vfZm073AT8c62n283J1v7zK1z--XS8X69xwzmTemIYaaEuoG0kLhkxXJXJRgJGaMgReMKkNCFlr3tSMdoK3TcuF4AygKRk7zb4cfLfe_ZkwRDXYYLDv9YhuCkrUtaCiogk8O4DGuxA8dmrr7ZAWV0DVPkFFQaUEVcUVUynB1PHpaD01A7Yv_DGypH8-6mlt3XcpFmPDCyZAVJWQCeMHbOf6iD489tMOvdqg7uNGpY9BGYUiB1nLdKM0Twck-wc4W7V3</recordid><startdate>198903</startdate><enddate>198903</enddate><creator>Chu, Alan</creator><creator>Stakely, Adrienne</creator><creator>Lin, Chang-Chyi</creator><creator>Cobb, Frederick R</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198903</creationdate><title>Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature</title><author>Chu, Alan ; Stakely, Adrienne ; Lin, Chang-Chyi ; Cobb, Frederick R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4439-bcb0c1d518b9023e3a65e4721c9a03e14239ac1798a4b830f74dbd4774311b533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Atrial Natriuretic Factor - pharmacology</topic><topic>Atrial Natriuretic Factor - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Disease - complications</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - physiopathology</topic><topic>Coronary heart disease</topic><topic>Dogs</topic><topic>Drug Evaluation, Preclinical</topic><topic>Heart</topic><topic>Hyperemia - drug therapy</topic><topic>Hyperemia - etiology</topic><topic>Hyperemia - physiopathology</topic><topic>Medical sciences</topic><topic>Microspheres</topic><topic>Time Factors</topic><topic>Vasodilation - drug effects</topic><topic>Wakefulness - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chu, Alan</creatorcontrib><creatorcontrib>Stakely, Adrienne</creatorcontrib><creatorcontrib>Lin, Chang-Chyi</creatorcontrib><creatorcontrib>Cobb, Frederick R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chu, Alan</au><au>Stakely, Adrienne</au><au>Lin, Chang-Chyi</au><au>Cobb, Frederick R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1989-03</date><risdate>1989</risdate><volume>64</volume><issue>3</issue><spage>600</spage><epage>606</epage><pages>600-606</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>The effects of atrial natriuretic peptide (ANP) on transmural myocardial blood flow distribution and the reactive hyperemic response in the presence and absence of flow-limiting coronary stenosis were examined in chronically instrumented conscious dogs. Ten-second coronary occlusion without subsequent flow restriction resulted in marked reactive hyperemic responses (Doppler flow probes), mean flow debt repayment was 481±55percent;. When the 10-second coronary occlusions were followed by a 20-second partial restriction that allowed normal preocclusion coronary inflow, the subsequent reactive hyperemia was significantly augmented, mean flow debt repayment was 938±91percent; (p&lt;0.05). Pretreatment with ANP (3μg/kg) did not alter the flow debt repayment after a 10-second occlusion without restriction (474±30percent;, NS) but attenuated the augmentation of reactive hyperemia resulting from the 20-second inflow restriction, flow debt repayment (613±±66percent;, NS). Regional myocardial blood flow to the ischemic region was measured during restricted inflow after a 10-second coronary occlusion before and after ANP pretreatment. Before ANP, subendocardial flow decreased (0.54±0.04 ml/min/g) and subepicardial flow significantly increased (1.03±0.12 ml/min/g) when compared with the nonischemk zone (subendocardial, 1.03±0.09 ml/min/g; subepicardial, 0.87±0.09 ml/ min/g, p&lt;0.05), indicating maldistribution of the restricted inflow. The resultant subendocardial-to-subepicardial ratio in the ischemic region was significantly decreased when compared with the nonischemic region (0.56±0.03 vs. 1.18±0.04, p&lt;0.05). After ANP pretreatment, subendocardial flow to the ischemic region significantly increased (0.71±0.07 ml/min/g, p&lt;0.05) and the subendocardial-to-subepicardial ratio in the ischemic zone was significantly unproved (0.91±0.10, p&lt;0.05). Myocardial flow measured daring coronary occlusion was not altered after ANP pretreatment, indicating no change in native collateral flow to the ischemic region. Myocardial oxygen consumption, aortic and left ventricular end-diastolic pressures, dP/dt, and heart rates were also not affected by pretreatment with ANP. These data indicate that ANP favorably redistributed blood flow to the subendocardium and reduced subendocardial ischemia after a transient occlusion in the presence of a flow limiting coronary stenosis. The reversal of subendocardial hypoperfusion by ANP hi the absence of alterations of intrinsic vascular reactivity or native collateral flow supports a dilation effect of ANP on the intramural arteries.</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>2521815</pmid><doi>10.1161/01.RES.64.3.600</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7330
ispartof Circulation research, 1989-03, Vol.64 (3), p.600-606
issn 0009-7330
1524-4571
language eng
recordid cdi_proquest_miscellaneous_78870760
source Freely Accessible Journals
subjects Animals
Atrial Natriuretic Factor - pharmacology
Atrial Natriuretic Factor - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Coronary Circulation - drug effects
Coronary Disease - complications
Coronary Disease - drug therapy
Coronary Disease - physiopathology
Coronary heart disease
Dogs
Drug Evaluation, Preclinical
Heart
Hyperemia - drug therapy
Hyperemia - etiology
Hyperemia - physiopathology
Medical sciences
Microspheres
Time Factors
Vasodilation - drug effects
Wakefulness - drug effects
title Effects of Atrial Natriuretic Peptide on Transmural Blood Flow and Reactive Hyperemia in the Presence of Flow-Limiting Coronary Stenosis in the Awake Dog: Evidence for Dilation of the Intramural Vasculature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A08%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Atrial%20Natriuretic%20Peptide%20on%20Transmural%20Blood%20Flow%20and%20Reactive%20Hyperemia%20in%20the%20Presence%20of%20Flow-Limiting%20Coronary%20Stenosis%20in%20the%20Awake%20Dog:%20Evidence%20for%20Dilation%20of%20the%20Intramural%20Vasculature&rft.jtitle=Circulation%20research&rft.au=Chu,%20Alan&rft.date=1989-03&rft.volume=64&rft.issue=3&rft.spage=600&rft.epage=606&rft.pages=600-606&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.RES.64.3.600&rft_dat=%3Cproquest_cross%3E78870760%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4439-bcb0c1d518b9023e3a65e4721c9a03e14239ac1798a4b830f74dbd4774311b533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78870760&rft_id=info:pmid/2521815&rfr_iscdi=true